Pediatric Rheumatology最新文献

筛选
英文 中文
Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China. 中国一项回顾性研究:卡那库单抗治疗冰冻素相关周期综合征的有效性和安全性。
IF 2.8 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-27 DOI: 10.1186/s12969-024-01023-w
Xiaona Zhu, Jiaqi Fan, Yanyan Huang, Yongbin Xu, Zhi Yang, Ruohang Weng, Ying Luo, Jun Yang, Tingyan He
{"title":"Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China.","authors":"Xiaona Zhu, Jiaqi Fan, Yanyan Huang, Yongbin Xu, Zhi Yang, Ruohang Weng, Ying Luo, Jun Yang, Tingyan He","doi":"10.1186/s12969-024-01023-w","DOIUrl":"https://doi.org/10.1186/s12969-024-01023-w","url":null,"abstract":"<p><strong>Objective: </strong>Cryopyrin-associated periodic syndrome (CAPS) is characterized by excessive IL-1β release resulting in systemic and organ inflammation. As an anti-IL-1 agent, canakinumab has been approved with all CAPS phenotypes in USA and European countries. However, the use of canakinumab in CAPS in Chinese patients was rarely reported. In this study, we aimed to assess the effectiveness and safety of canakinumab in Chinese patients with CAPS.</p><p><strong>Methods: </strong>Patients with CAPS treated with canakinumab were included. Clinical data were collected retrospectively from medical records. Treatment response was evaluated by CAPS disease activity score, C-reactive protein (CRP), and/or serum amyloid A (SAA) levels. Data was analyzed at canakinumab initiation, at months 1, 3, 6, 9, and 12, or the last follow-up.</p><p><strong>Results: </strong>A total of 10 CAPS patients were included. 40% of patients were males, the median age at disease onset was 2.5 (2.5, 6) days and the median duration of follow-up while on canakinumab was 22.5 (8.5, 27.5) months. 80% (8/10) of CAPS patients presented with moderate-severe disease activity before the canakinumab treatment. 30% (3/10) of patients required canakinumab dose increase to control disease activity. After treatments, 60% (6/10) of CAPS patients achieved complete remission without relapse and the rest showed minimal disease activity. Clinical symptoms such as fever and rash were improved significantly in most patients (80%). Although abnormal imaging in brain MRI remained in over half of those patients, neurological manifestations were all relieved. 60% (6/10) of patients received prednisone before starting canakinumab therapy and five of them discontinued prednisone later. The most common adverse event was infection (40%). No serious adverse events occurred during the treatment of canakinumab.</p><p><strong>Conclusions: </strong>Canakinumab may be effective and tolerable for Chinese CAPS patients, helping to reduce the dosage of corticosteroids. However, additional trials on large samples are required to further evaluate its efficacy and safety in China.</p>","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"22 1","pages":"87"},"PeriodicalIF":2.8,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report 14个月大的女性抗MDA5幼年皮肌炎患者并发肝病:病例报告
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-17 DOI: 10.1186/s12969-024-01021-y
Mitchell Kinkor, Sameena Hameed, Alexander Kats, Voytek Slowik, Emily Fox, Maria Ibarra
{"title":"14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report","authors":"Mitchell Kinkor, Sameena Hameed, Alexander Kats, Voytek Slowik, Emily Fox, Maria Ibarra","doi":"10.1186/s12969-024-01021-y","DOIUrl":"https://doi.org/10.1186/s12969-024-01021-y","url":null,"abstract":"Juvenile Dermatomyositis (JDM) is a rare disorder with subtypes associated with different myositis-specific antibodies (MSAs) including anti-MDA5. Hepatic involvement in JDM is rare and has not previously been documented in anti-MDA5 JDM. There is a lack of formal research on treatment protocols for anti-MDA5 JDM, though tofacitinib is a highly regarded emerging therapy. A previously healthy 14-month-old Hispanic female presented to a pediatric rheumatology clinic with eight months of worsening rash, weakness, periorbital edema, intermittent fevers, and weight loss. Her physical exam was notable for fever, thinning of hair, heliotrope rash, periorbital edema, violaceous macules on her bilateral elbows, forearms, arms, and knees, arthritis, Gottron’s sign, and hepatomegaly. The patient was admitted, and symptoms progressed to include hypoxemia. Subsequent workup was notable for ground glass opacities of bilateral lung fields on chest CT, myositis visualized on MRI and confirmed with muscle biopsy, and liver biopsy showing nonspecific signs of liver injury. After a thorough infectious disease workup to rule out concomitant infection, the patient was started on high-dose steroids and induction with cyclophosphamide. She responded well with disease remission maintained with tofacitinib in the outpatient setting. Our patient is notable due to her young age at presentation, histopathologically confirmed liver injury, and response to treatment. The case adds to the growing body of literature supporting tofacitinib for anti-MDA5 JDM in the pediatric population. Future research can better standardize effective treatment protocols and define the mechanism of liver involvement. For patients with nonspecific liver injury, muscular, and cutaneous disease, anti-MDA5 JDM should be considered in the differential diagnosis with treatment options including tofacitinib for confirmed cases.","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"1 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting 2024 年儿童关节炎和风湿病学研究联盟(CARRA)年度科学会议论文集
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-13 DOI: 10.1186/s12969-024-00998-w
{"title":"Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting","authors":"","doi":"10.1186/s12969-024-00998-w","DOIUrl":"https://doi.org/10.1186/s12969-024-00998-w","url":null,"abstract":"&lt;h3&gt;Katherine Nowicki&lt;sup&gt;1&lt;/sup&gt;, Nathan Rogers&lt;sup&gt;2&lt;/sup&gt;, Carson Keeter&lt;sup&gt;3&lt;/sup&gt;, Nathan Donaldson&lt;sup&gt;1&lt;/sup&gt;, Jennifer Soep&lt;sup&gt;1&lt;/sup&gt;, Yongdong Zhao&lt;sup&gt;4&lt;/sup&gt;\u0000&lt;/h3&gt;&lt;h4&gt;\u0000&lt;sup&gt;1&lt;/sup&gt;University of Colorado, Children’s Hospital Colorado; &lt;sup&gt;2&lt;/sup&gt;Children’s Hospital Colorado; &lt;sup&gt;3&lt;/sup&gt;University of Colorado; &lt;sup&gt;4&lt;/sup&gt;Seattle Children’s Hospital&lt;/h4&gt;&lt;h5&gt;\u0000&lt;b&gt;Correspondence:&lt;/b&gt; Katherine Nowicki&lt;/h5&gt;&lt;p&gt;\u0000&lt;i&gt;Pediatric Rheumatology 2024&lt;/i&gt;, &lt;b&gt;22(S1):&lt;/b&gt;A1&lt;/p&gt;&lt;br/&gt;&lt;p&gt;Background: Chronic Nonbacterial Osteomyelitis (CNO) is characterized by sterile inflammatory bone lesions and most commonly affects skeletally immature children. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first-line treatment, but in some cases second-line treatments including methotrexate, TNF-alpha inhibitors, and bisphosphonates are required. It remains unclear which patients are most likely to respond to NSAIDs or require a second-line treatment based on their initial presentation. In this study, we sought to describe our CNO cohort and to determine which clinical variables are associated with response to NSAID monotherapy versus requiring a second-line medication.&lt;/p&gt;&lt;p&gt;Methods : A retrospective chart review of patients with a diagnosis of CNO made before 18 years of age who attended the CNO clinic at Children’s Hospital Colorado between 1/1/05 and 1/31/22 was performed. The standardized treatment approach involved 6 months of NSAIDs, followed by a trial of discontinuation in responders. Patients who failed the discontinuation trial were given a longer NSAID course. Patients with spinal involvement, patients with comorbidities such as psoriasis or inflammatory bowel disease, and NSAID-non-responders were treated with second-line therapies. Clinical characteristics were recorded, including which of 6 regions (head and face, neck and back, upper torso, upper extremities, lower torso, lower extremities) were affected by CNO. Patients were divided into three groups: NSAID-short (NSAID monotherapy for 3 to &lt; 7 months), NSAID-long (NSAID monotherapy for ≥7 months), or second-line treatment. A multiple linear regression model was constructed to determine the relationship between total NSAID monotherapy days and relevant predictors. Multiple logistic regression was used to determine the odds of needing second-line treatment when considering those same predictors. Both models contained combinations of variables which minimized the Akaike Information Criteria (AIC), resulting in models with low multicollinearity and high predictive power.&lt;/p&gt;&lt;p&gt;Results : 164 patients fulfilled inclusion criteria and 70 patients were excluded. Cohort characteristics overall and for each of the 3 treatment groups are presented in Table 1. Comparison between the NSAID-short and NSAID-long groups showed that patients with unifocal disease at diagnosis required 47% less days of NSAID treatment than those with multifocal disease at diagnosis (Table 2). Comparison of the NSAID mon","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"12 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142194674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protracted febrile myalgia syndrome in children with familial Mediterranean fever – systematic review and a case report 家族性地中海热患儿的持续发热性肌痛综合征--系统综述和病例报告
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-10 DOI: 10.1186/s12969-024-01019-6
Toni Hospach, Friederike Blankenburg, Anita Heinkele, Thekla von Kalle, Yosef Uziel, Tillmann Kallinich, Kristina Rücklová
{"title":"Protracted febrile myalgia syndrome in children with familial Mediterranean fever – systematic review and a case report","authors":"Toni Hospach, Friederike Blankenburg, Anita Heinkele, Thekla von Kalle, Yosef Uziel, Tillmann Kallinich, Kristina Rücklová","doi":"10.1186/s12969-024-01019-6","DOIUrl":"https://doi.org/10.1186/s12969-024-01019-6","url":null,"abstract":"Protracted febrile myalgia syndrome (PFMS) is a rare manifestation of familial Mediterranean fever (FMF), characterized by myalgia, fever and elevated inflammatory markers lasting several weeks. As the hallmark of FMF are short episodes of disease symptoms, the long duration of PFMS may lead to a delayed diagnosis and treatment. 1. To perform a review of literature and rheumatology textbooks focused on clinical features and treatment of PFMS in children. 2. To present our own case. All articles in Pub Med generated using the keywords “protracted febrile myalgia” and information on PFMS in seven rheumatology textbooks were collected. The systematic review was supplemented with our own case presentation. In total, 18 articles with 78 pediatric patients (including our own) were retrieved. More than half of the patients presented with PFMS as the first manifestation of FMF. All complained of myalgia, 65% of abdominal pain and 26% had a rash. Corticosteroids (CS) were effective in 77%. In all CS-refractory cases, anakinra was shown efficient. MRI was used in 5 patients and showed myositis in all of them. The scrutiny of seven rheumatology textbooks showed that PFMS presenting with myalgia was mentioned in six. Possible accompanying symptoms were described only once, the long duration of symptoms twice, the efficacy of corticosteroids three times and anakinra only once. The presented 6 year old patient manifested with fever, myalgia, abdominal pain and petechial rash lasting 6 weeks. She had undergone multiple diagnostic procedures before her parents mentioned a positive family history for FMF. The subsequent genetic testing confirmed a homozygosity for M694V pathogenic variant in the MEFV gene. The long duration of PFMS may be misleading to clinicians especially if PFMS occurs at manifestation of FMF. The fact that more than half of the reported patients experienced PFMS as the presenting symptom of FMF is one of the key findings of our study. Our case presentation demonstrates the importance of genetic testing early in suspected autoinflammatory diseases. Furthermore, MRI may be an important diagnostic tool showing myositis in PFMS.","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"25 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142194654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proceedings of the 31st European Paediatric Rheumatology Congress: part 2 第 31 届欧洲儿科风湿病大会论文集:第二部分
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-09 DOI: 10.1186/s12969-024-01005-y
{"title":"Proceedings of the 31st European Paediatric Rheumatology Congress: part 2","authors":"","doi":"10.1186/s12969-024-01005-y","DOIUrl":"https://doi.org/10.1186/s12969-024-01005-y","url":null,"abstract":"&lt;h3&gt;JIA (oligo, poly, psoriatic)&lt;/h3&gt;&lt;h4&gt;P177 Investigation of functionality, participation, and biopsychosocial status of individuals with JIA according to disease activity&lt;/h4&gt;&lt;h5&gt;Orkun Tüfekçi&lt;sup&gt;1&lt;/sup&gt;, Sinan Buran&lt;sup&gt;2&lt;/sup&gt;, Nur B. Karaca&lt;sup&gt;1&lt;/sup&gt;, Emil Aliyev&lt;sup&gt;3&lt;/sup&gt;, Yağmur Bayındır&lt;sup&gt;3&lt;/sup&gt;, Yelda Bilginer&lt;sup&gt;3&lt;/sup&gt;, Edibe Ünal&lt;sup&gt;2&lt;/sup&gt;, Seza Özen&lt;sup&gt;3&lt;/sup&gt;\u0000&lt;/h5&gt;&lt;h6&gt;\u0000&lt;sup&gt;1&lt;/sup&gt;Department of Basic Physiotherapy and Rehabilitation, Hacettepe University Institute of Health Sciences; &lt;sup&gt;2&lt;/sup&gt;Department of Heart and Respiratory Physiotherapy and Rehabilitation, Hacettepe University Faculty of Physical Therapy and Rehabilitation; &lt;sup&gt;3&lt;/sup&gt;Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Türkiye&lt;/h6&gt;&lt;h5&gt;\u0000&lt;b&gt;Correspondence:&lt;/b&gt; Orkun Tüfekçi&lt;/h5&gt;&lt;p&gt;&lt;i&gt;Pediatric Rheumatology 2024&lt;/i&gt;, &lt;b&gt;22(2)&lt;/b&gt;: PReS24-ABS-1330&lt;/p&gt;&lt;br/&gt;&lt;p&gt;&lt;b&gt;Introduction:&lt;/b&gt; The relationship between disease activity status in JIA and the functionality, participation, and psychosocial status of these individuals has been emphasized. However, upon reviewing the literature, the need for evaluation of disease activity status in JIA in these aspects is reported (1, 2).&lt;/p&gt;&lt;p&gt;&lt;b&gt;Objectives:&lt;/b&gt; This study aimed to investigate the functionality, participation, and biopsychosocial status of individuals with JIA according to disease activity.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Methods:&lt;/b&gt; Our study included fifty individuals (31 girls, 19 boys) diagnosed with JIA, of whom 35 had oligoarticular and 15 had polyarticular JIA, and who were followed up with routine controls. Demographic information of the participants was documented, and disease activity status was assessed using the Juvenile Arthritis Disease Activity Score in 71 joints (JADAS-71). Functionality was measured using the Childhood Health Assessment Questionnaire (CHAQ), participation was evaluated using the Child and Adolescent Scale of Participation (CASP), and biopsychosocial status was examined using the Juvenile Arthritis Biopsychosocial Questionnaire (JAB-Q). Disease activity was categorized based on the JADAS-71 score: ≤1 indicated inactive disease, while &gt;10.5 indicated high disease activity (3). Group characteristics were compared using the Mann-Whitney U test.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results:&lt;/b&gt; Demographic characteristics of inactive and high disease activity JIA patients were similar (p&gt;0.05). CHAQ pain, general well-being, and total score, CASP home participation and total score, JAB-Q-child disease activity, joint, functionality, fatigue, and total scores were significantly better in favor of the inactive group; ESR value and number of affected active joints were higher in individuals with high disease activity (p&lt;0.05).&lt;/p&gt;&lt;p&gt;&lt;b&gt;Conclusion:&lt;/b&gt; This study showed that individuals with JIA exhibiting high disease activity were more affected in functionality, participation, and biopsychosocial status compared to those with inactive disease. The findings of this s","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"162 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142194691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of spine pain among Tunisian children and adolescents and related factors 突尼斯儿童和青少年脊柱疼痛的患病率及相关因素
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-09 DOI: 10.1186/s12969-024-01007-w
Alia Fazaa, Ines Cherif, Saoussen Miladi, Hiba boussaa, Yasmine makhlouf, Kaouther ben abdelghani, Ahmed laatar
{"title":"Prevalence of spine pain among Tunisian children and adolescents and related factors","authors":"Alia Fazaa, Ines Cherif, Saoussen Miladi, Hiba boussaa, Yasmine makhlouf, Kaouther ben abdelghani, Ahmed laatar","doi":"10.1186/s12969-024-01007-w","DOIUrl":"https://doi.org/10.1186/s12969-024-01007-w","url":null,"abstract":"The prevalence of back and neck pain is common in children and adolescents, and in some series the numbers are alarming. Various risk factors have been identified, although some are controversial. To determine the prevalence of neck and back pain in children and adolescents and to investigate the potential association with various risk factors identified in the literature. We established a questionnaire targeting parents of children and adolescents aged between 6 and 18 years old in Tunisia. The recruitment of participants was done online using the Google Forms application. The questionnaire was divided into 2 parts: Part one collected the sociodemographics characteristics of the participants : age, gender, body mass index (BMI), exposure to passive smoking, the practice of a physical activity, puberty status and age at puberty if applicable, type and weight of the schoolbag, mean daily time spent on electronic devices, type of school the child attends (private/public), mode of transport from home to school, parental history of neck and/or back pain (mid or low back pain (LBP)), posture of the sitting position of the child, and finally whether the child reports neck/ back pain. The second part was aimed at parents whose child reported neck and/or back pain. We asked about the weekly frequency of neck/back pain, school absenteeism due to neck/back pain, whether it prevented the child from practicing physical activity and, finally, whether the child had ever seen a doctor/chiropractor/physiotherapist for their neck/back pain. Eighty-eight children (45 females, 43 males) were enrolled. Mean age was 11.9 ± 3.8 years [6–18]. Mean BMI was 18.8 ± 4.2 [15.8–35.5]. Thirty-four (38.6%) were pubescent. Twenty-five (28.4%) children were exposed to passive smoking. Parental history of spine pain was found in 58% of cases. A poor sitting position was noted in n = 49 (55.7%). Mean daily screen time was 88.3 ± 75.56 min [0-360]. Prevalence of spine pain was 44% (n = 39) distributed as follows: neck pain (n = 21, 23.8%), mid back pain (n = 15, 17%), LBP (n = 26, 29.5%), neck, mid back and low back pain (n = 4, 4.5%) Professional help seeking for spine pain in children was reported by 15 participants (25.3%). Among them, 20.3% visited a physician and 5% consulted a chiropractor or physiotherapist. A significant correlation was found between spine pain and age (p = 0.006) and BMI (p = 0.006). A significant association was found between LBP and exposure to passive smoking, puberty status, type of school bag and poor posture. A positive parental history of spine pain was significantly associated with the presence of spine pain in their children with p = 0.053 (neck pain), p = 0.013 (back pain) and p &lt; 0.00 (LBP) respectively. A significant association was found between the presence of spine pain and school absenteeism, participation in sports, consultation with a doctor or physiotherapist/chiropractor (p &lt; 0.0001 respectively). The prevalence of spinal pain was frequ","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"23 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142194671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proceedings of the 31st European Paediatric Rheumatology Congress: part 1 第 31 届欧洲儿科风湿病大会论文集:第一部分
IF 2.5 3区 医学
Pediatric Rheumatology Pub Date : 2024-09-09 DOI: 10.1186/s12969-024-01004-z
{"title":"Proceedings of the 31st European Paediatric Rheumatology Congress: part 1","authors":"","doi":"10.1186/s12969-024-01004-z","DOIUrl":"https://doi.org/10.1186/s12969-024-01004-z","url":null,"abstract":"&lt;h3&gt;Autoinflammatory diseases&lt;/h3&gt;&lt;h4&gt;OR01 Assessment of ADA2 activity levels: report from the Italian study group on DADA2&lt;/h4&gt;&lt;h5&gt;Alessia Cafaro&lt;sup&gt;1&lt;/sup&gt;, Roberta Caorsi&lt;sup&gt;2&lt;/sup&gt;, Enrico Drago&lt;sup&gt;3&lt;/sup&gt;, Alice Grossi&lt;sup&gt;4&lt;/sup&gt;, Sebastiano Barco&lt;sup&gt;1&lt;/sup&gt;, Chiara Conti&lt;sup&gt;3&lt;/sup&gt;, Flippo Maestrini&lt;sup&gt;5&lt;/sup&gt;, Maurizio Miano&lt;sup&gt;6&lt;/sup&gt;, Francesca Fioredda&lt;sup&gt;6&lt;/sup&gt;, Maria Carla Giarrattana&lt;sup&gt;6&lt;/sup&gt;, Federica Brazaghi&lt;sup&gt;7&lt;/sup&gt;, Michela Lupia&lt;sup&gt;6&lt;/sup&gt;, Stefano Volpi&lt;sup&gt;2, 3&lt;/sup&gt;, Riccardo Papa&lt;sup&gt;2&lt;/sup&gt;, Francesca Schena&lt;sup&gt;2&lt;/sup&gt;, Alessandra Mortellaro&lt;sup&gt;7&lt;/sup&gt;, Isabella Ceccherini&lt;sup&gt;4&lt;/sup&gt;, Alessandro Aiuti&lt;sup&gt;7&lt;/sup&gt;, Carlo Dufour&lt;sup&gt;6&lt;/sup&gt;, Giuliana Cangemi&lt;sup&gt;1&lt;/sup&gt;, Marco Gattorno&lt;sup&gt;2&lt;/sup&gt; and Italian study group on DADA2&lt;/h5&gt;&lt;h6&gt;\u0000&lt;sup&gt;1&lt;/sup&gt;Central Laboratory of Analysis; &lt;sup&gt;2&lt;/sup&gt;Rheumatology and Autoinflammatory Diseases, IRCCS Istituto Giannina Gaslini; &lt;sup&gt;3&lt;/sup&gt;DINOGMI, University of Genova; &lt;sup&gt;4&lt;/sup&gt;Genetics of Rare Diseases, IRCCS Istituto Giannina Gaslini; &lt;sup&gt;5&lt;/sup&gt;University of Genova; &lt;sup&gt;6&lt;/sup&gt;Hematology, IRCCS Istituto Giannina Gaslini, Genova; &lt;sup&gt;7&lt;/sup&gt;IRCCS Ospedale San Raffaele, Milano, Italy&lt;/h6&gt;&lt;h5&gt;\u0000&lt;b&gt;Correspondence:&lt;/b&gt; Roberta Caorsi&lt;/h5&gt;&lt;p&gt;&lt;i&gt;Pediatric Rheumatology 2024&lt;/i&gt;, &lt;b&gt;22(2):&lt;/b&gt;PReS24-ABS-1499&lt;/p&gt;&lt;br/&gt;&lt;p&gt;&lt;b&gt;Introduction:&lt;/b&gt; Adenosine Deaminase 2 deficiency (DADA2) is a rare monogenic autoinflammatory disease resulting from loss-of-function mutations in ADA2. Functional assays are crucial for early diagnosis. In 2021, we introduced a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to assess ADA2 activity from dried plasma spot (DPS) [1].&lt;/p&gt;&lt;p&gt;&lt;b&gt;Objectives:&lt;/b&gt; To define cut-offs of ADA2 activity in the normal population and to assess the test’s utility in a large multicentre real-life cohort of patients with suspected DADA2.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Methods:&lt;/b&gt; At first, ADA2 activity was tested in 17 patients with genetically confirmed DADA2, 23 clinically healthy and genetically confirmed carriers, and 132 healthy donors. The test was then performed in 19 new diagnoses of DADA2 later confirmed genetically, 4 carriers subsequently confirmed genetically, 195 patients with other related conditions. Receiver Operating Curves (ROC) analysis evaluated the diagnostic performance of ADA2 activity in DPS. Spearman correlation coefficients were employed to investigate the relations between ADA2 activity in DPS and age. Significance was determined at a threshold of P&lt;0.05 for all analyses, with two-tailed tests utilized.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results:&lt;/b&gt; ADA2 activity in DPS effectively discriminated patients with DADA2 from carriers (AUC=0.946, P&lt;0.001) and carriers from patients with suspected but non-DADA2 conditions (AUC=0.890, P&lt;0.001) with high sensitivity and specificity. A significant inverse correlation existed between DADA2 activity in DPS and age (P&lt;0.0001). The ADA2 activity cut-off values in DPS were identified as follows: ≤ 0.09 mU/mL for p","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"29 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142194690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The assessment of bone health in children with juvenile idiopathic arthritis; comparison of different imaging-based methods. 评估幼年特发性关节炎患儿的骨骼健康状况;比较不同的成像方法。
IF 2.8 3区 医学
Pediatric Rheumatology Pub Date : 2024-08-29 DOI: 10.1186/s12969-024-01018-7
Thomas Augdal, Oskar Angenete, Pia Zadig, Anette Lundestad, Ellen Nordal, Xieqi Shi, Karen Rosendahl
{"title":"The assessment of bone health in children with juvenile idiopathic arthritis; comparison of different imaging-based methods.","authors":"Thomas Augdal, Oskar Angenete, Pia Zadig, Anette Lundestad, Ellen Nordal, Xieqi Shi, Karen Rosendahl","doi":"10.1186/s12969-024-01018-7","DOIUrl":"10.1186/s12969-024-01018-7","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is increasingly being recognized in children, mostly secondary to systemic underlying conditions or medication. However, no imaging modality currently provides a full evaluation of bone health in children. We compared DXA, a radiographic bone health index (BHI (BoneXpert) and cone-beam CT for the assessment of low bone mass in children with juvenile idiopathic arthritis (JIA).</p><p><strong>Methods: </strong>Data used in the present study was drawn from a large multicentre study including 228 children aged 4-16 years, examined between 2015 and 2020. All had a radiograph of the left hand, a DXA scan and a cone-beam CT of the temporomandibular joints within four weeks of each other. For the present study, we included 120 subjects, selected based on DXA BMD and BoneXpert BHI to secure values across the whole range to be tested.</p><p><strong>Results: </strong>One hundred and twenty children (60.0% females) were included, mean age 11.6 years (SD 3.1 years). There was a strong correlation between the absolute values of BHI and BMD for both total body less head (TBLH) (r = 0.75, p < 0.001) and lumbar spine (L1-L4) (r = 0.77, p < 0.001). The correlation between BHI standard deviation score (SDS) and BMD TBLH Z-scores was weak (r = 0.34) but significant (0 = 0.001), varying from weak (r = 0.31) to moderate (r = 0.42) between the three study sites. Categorizing BHI SDS and DXA BMD Z-scores on a 0-5 scale yielded a weak agreement between the two for both TBLH and LS, with w-kappa of 0.2, increasing to 0.3 when using quadratic weights. The agreement was notably higher for one of the three study sites as compared to the two others, particularly for spine assessment, yielding a moderate kappa value of 0.4 - 0.5. For cone-beam CT, based on a 1-3 scale, 59 out of 94 left TMJ's were scored as 1 and 31 as score 2 by the first observer vs. 87 and 7 by the second observer yielding a poor agreement (kappa 0.1).</p><p><strong>Conclusions: </strong>Categorizing DXA LS and automated radiographic Z-scores on a 0-5 scale gave a weak to moderate agreement between the two methods, indicating that a hand radiograph might provide an adjuvant tool to DXA when assessing bone health children with JIA, given thorough calibration is performed.</p>","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"22 1","pages":"80"},"PeriodicalIF":2.8,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study. JIA 患者抗核抗体与 HLA 的遗传关联:一项瑞典队列研究。
IF 2.8 3区 医学
Pediatric Rheumatology Pub Date : 2024-08-26 DOI: 10.1186/s12969-024-01017-8
Raya Saleh, Erik Sundberg, Mia Olsson, Katarina Tengvall, Lars Alfredsson, Ingrid Kockum, Leonid Padyukov, Helena Erlandsson Harris
{"title":"Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study.","authors":"Raya Saleh, Erik Sundberg, Mia Olsson, Katarina Tengvall, Lars Alfredsson, Ingrid Kockum, Leonid Padyukov, Helena Erlandsson Harris","doi":"10.1186/s12969-024-01017-8","DOIUrl":"10.1186/s12969-024-01017-8","url":null,"abstract":"<p><strong>Background: </strong>Juvenile Idiopathic Arthritis (JIA) is a complex autoimmune disease and the most common chronic rheumatological disease affecting children under the age of 16. The etiology of JIA remains poorly understood, but evidence suggests a significant genetic predisposition.</p><p><strong>Methods: </strong>We analyzed a Swedish cohort of 329 JIA patients and 728 healthy adult controls using the Illumina OmniExpress array for genotyping. HLA alleles were imputed from GWAS data using the SNP2HLA algorithm.</p><p><strong>Results: </strong>Case-control analysis yielded 12 SNPs with genome-wide significant association to JIA, all located on chromosome 6 within the MHC class II gene region. Notably, the top SNP (rs28421666) was located adjacent to HLA-DQA1 and HLA-DRB1. HLA-DRB1*08:01, HLA-DQA1*04:01, and HLA-DQB1*04:02 were the haplotypes most strongly associated with an increased risk of JIA in the overall cohort. When analyzing disease specific subtypes, these alleles were associated with oligoarthritis and RF-negative polyarthritis. Within the complex linkage disequilibrium of the HLA-DRB1-DQA1-DQB1 haplotype, our analysis suggests that HLA-DRB1*08 might be the primary allele linked to JIA susceptibility. The HLA-DRB1*11 allele group was also independently associated with JIA and specifically enriched in the oligoarthritis patient group. Additionally, our study revealed a significant correlation between antinuclear antibody (ANA) positivity and specific HLA alleles. The ANA-positive JIA group showed stronger associations with the HLA-DRB1-DQA1-DQB1 haplotype, HLA-DRB1*11, and HLA-DPB1*02, suggesting a potential connection between genetic factors and ANA production in JIA. Furthermore, logistic regression analysis reaffirmed the effects of HLA alleles, female sex, and lower age at onset on ANA positivity.</p><p><strong>Conclusions: </strong>This study identified distinct genetic associations between HLA alleles and JIA subtypes, particularly in ANA-positive patients. These findings contribute to a better understanding of the genetic basis of JIA and provide insights into the genetic control of autoantibody production in ANA-positive JIA patients. This may inform future classification and personalized treatment approaches for JIA, ultimately improving patient outcomes and management of this disease.</p>","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"22 1","pages":"79"},"PeriodicalIF":2.8,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey. 小儿家族性地中海热人工智能生成工具的可靠性:多中心专家调查的启示。
IF 2.8 3区 医学
Pediatric Rheumatology Pub Date : 2024-08-23 DOI: 10.1186/s12969-024-01011-0
Saverio La Bella, Marina Attanasi, Annamaria Porreca, Armando Di Ludovico, Maria Cristina Maggio, Romina Gallizzi, Francesco La Torre, Donato Rigante, Francesca Soscia, Francesca Ardenti Morini, Antonella Insalaco, Marco Francesco Natale, Francesco Chiarelli, Gabriele Simonini, Fabrizio De Benedetti, Marco Gattorno, Luciana Breda
{"title":"Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey.","authors":"Saverio La Bella, Marina Attanasi, Annamaria Porreca, Armando Di Ludovico, Maria Cristina Maggio, Romina Gallizzi, Francesco La Torre, Donato Rigante, Francesca Soscia, Francesca Ardenti Morini, Antonella Insalaco, Marco Francesco Natale, Francesco Chiarelli, Gabriele Simonini, Fabrizio De Benedetti, Marco Gattorno, Luciana Breda","doi":"10.1186/s12969-024-01011-0","DOIUrl":"10.1186/s12969-024-01011-0","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatric familial Mediterranean fever (FMF).</p><p><strong>Methods: </strong>Fifteen questions repeated thrice on pediatric FMF were prompted to the popular generative AI tool Microsoft Copilot with Chat-GPT 4.0. Nine pediatric rheumatology experts rated response accuracy with a blinded mechanism using a Likert-like scale with values from 1 to 5.</p><p><strong>Results: </strong>Median values for overall responses at the initial assessment ranged from 2.00 to 5.00. During the second assessment, median values spanned from 2.00 to 4.00, while for the third assessment, they ranged from 3.00 to 4.00. Intra-rater variability showed poor to moderate agreement (intraclass correlation coefficient range: -0.151 to 0.534). A diminishing level of agreement among experts over time was documented, as highlighted by Krippendorff's alpha coefficient values, ranging from 0.136 (at the first response) to 0.132 (at the second response) to 0.089 (at the third response). Lastly, experts displayed varying levels of trust in AI pre- and post-survey.</p><p><strong>Conclusions: </strong>AI has promising implications in pediatric rheumatology, including early diagnosis and management optimization, but challenges persist due to uncertain information reliability and the lack of expert validation. Our survey revealed considerable inaccuracies and incompleteness in AI-generated responses regarding FMF, with poor intra- and extra-rater reliability. Human validation remains crucial in managing AI-generated medical information.</p>","PeriodicalId":54630,"journal":{"name":"Pediatric Rheumatology","volume":"22 1","pages":"78"},"PeriodicalIF":2.8,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信